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INTRODUCTION
Histoplasma capsulatum (H. capsulatum) is endemic in the mid-
western United States and central America.1 It causes a wide range 
of clinical syndromes, ranging from asymptomatic to life-threatening 
disseminated disease. The extent of disease depends on the number 
of conidia inhaled and the host immune system. Most of cases (50-
90%) in immunocompetent individuals are asymptomatic and 80% 
of symptomatic infections are self-limited and require no therapy. 
Initial exposure to H. capsulatum is usually by inhalation of the 
conidia into the respiratory tract and may result in pneumonia or 
chronic cavitary pulmonary infection. Central nervous system (CNS) 
involvement occurs in 5 to 10% of cases of disseminated histoplas-
mosis.  Clinical presentations of CNS histoplasma infection include 
meningitis, focal brain, or spinal cord lesions (histoplasmoma), stroke 
syndromes, and encephalitis. 
We report a male patient with a recent history of exposure to 
chickens who presented with confusion, stroke, and a brain lesion. 
He was treated with liposomal amphotericin B then itraconazole with 
good clinical response.
CASE REPORT
A 58-year-old man with past medical history of testicular cancer 
status post left orchiectomy 30 years prior to presentation. He 
presented with four-days history of confusion, auditory and visual 
hallucination, ataxia, urinary incontinence, and right-sided weakness. 
Two to three weeks prior to this presentation, he developed insomnia, 
worsening headaches, and right facial pain. He denied neck pain, stiff-
ness, fever, bowel incontinence or seizure activity.
He took care of his friend’s chickens for six weeks up until four 
weeks prior to admission. On examination, he appeared sick, lethar-
gic, and confused. He manifested right-sided weakness (upper and 
lower extremities) with motor function of 4/5. He had no neck stiff-
ness or Kerning’s sign. The examination was otherwise normal. 
Initial workup showed peripheral white blood cells (WBC) 4.8 K/
uL (normal 4.5 - 11.0 K/uL), hemoglobin 14.5 gm/dl (normal 13.5 - 
16.5 gm/dl), and platelets 255 K/uL (normal 150 - 400 K/uL). The 
patient had a lumbar puncture with clear cerebrospinal fluid (CSF): 
opening pressure 14 cm H2O (normal 10 - 25 cm H2O), red blood 
cells (RBC) 10 cells/μl (normal < 5 cells/μl), WBC 170 cells/μl 
(normal < 5 cells/μl), neutrophils 69%, lymphocytes 20%, glucose 
25 mg/dl (normal 40 - 75 mg/dl), and protein 150 mg/dl (normal 
15 - 40 mg/dl). Gram stain showed moderate neutrophils; no organ-
isms were seen. CSF herpes simplex virus and varicella zoster PCR 
were negative. 
Computed tomography (CT) of the head and cervical spine showed 
no acute intracranial hemorrhage or fractures. Magnetic resonance 
image (MRI) of the brain showed a 1 cm rounded enhancing nodule 
along the anterior pons (Figure 1) and hyperintense lesions within the 
posterior limb of the left internal capsule and right caudate nucleus 
(Figure 2). The CT scan of the chest was normal. 
The patient was started on acyclovir, vancomycin, and meropenem 
for suspected meningoencephalitis. Lumbar puncture was repeated 
on hospital day three as there was no clinical improvement. CSF 
WBC was 220 cells/μl, neutrophils 75%, lymphocytes 19%, glucose 
20 mg/dl (normal 40 - 75), and protein 187 mg/dl (normal 15 - 40). 
Repeat MRI on day four showed progression of the acute stroke to 
involve the left thalamus, anterior limb of the right internal capsule, 
and right caudate nucleus.
Figure 1. MRI of the head showed a 1 cm round enhancing nodule along the 
anterior pons. 
The CSF histoplasma antigen was positive at 14.5 ng/ml on hos-
pital day six. Liposomal amphotericin B was started for treatment of 
CNS histoplasmosis. Acyclovir, vancomycin, and meropenem were 
discontinued. Urine histoplasma antigen was negative, but the serum 
antigen was positive at 1.05 ng/ml. He was treated with six weeks of 
liposomal amphotericin B followed by 18 months of itraconazole. The 
CSF fungal culture grew H. capsulatum after 13 days of incubation.
Follow-up MRI of the brain, five months later, showed decreasing 
edema around the ring enhancing lesion. The patient improved with 
time, his right-sided weakness and ataxia resolved. He was able to 
cook and perform simple tasks around the house but continued to 
have minimal impairment in cognition. Repeat lumbar puncture after 
18 months showed red blood cells 0 cells/μl, WBC 0 cells/μl, glucose 
63 mg/dl (normal 40 - 75), protein 65 mg/dl (normal 15 - 40). Itra-
conazole was discontinued after 18 months of treatment. 
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Figure 2. MRI revealed hyperintense lesions within the posterior limb of the 
left internal capsule and right caudate nucleus. 
DISCUSSION
Histoplasma capsulatum is a dimorphic fungus and considered one 
of the most common fungal respiratory infections in the world.1 The 
most common system involved in symptomatic histoplasma infection 
is the pulmonary system. CNS involvement occurs in 5 to 10% of 
cases of disseminated histoplasmosis.2 The CNS invasion is usually 
hematogenous; the most common source of invasion is pulmonary 
infection.3 The most common presentation of CNS histoplasmosis 
is meningitis, either subacute or chronic.2 Other clinical syndromes 
include focal brain or spinal cord lesions (histoplasmoma), stroke 
syndromes, and encephalitis. CNS histoplasmosis should be consid-
ered in patients with chronic meningitis or brain lesions in endemic 
area especially if there is a strong exposure history like to chicken 
or bat droppings. Our patient was immunocompetent and his clini-
cal presentation was suggestive of meninecephalitis and stroke. His 
brain imaging showed evidence of a stroke with brain lesion. 
In a large multicenter retrospective study of 77 patients with CNS 
histoplasmosis, 22 patients (29%) were immunocompetent.4 The 
most sensitive test used for diagnosis was histoplasma antigen in 
the CSF. It was detected in 35 of 53 (66%) with higher sensitivity 
in immunocompromised patients 30 of 37 (81%). The second most 
sensitive test was antibody detection by immunodiffusion or comple-
ment fixation in the CSF. It was positive in 19 of 32 tested (59%) 
with comparable results between immunocompetent and immu-
nocompromised patients. CSF culture or brain tissue biopsy were 
diagnostic of histoplasmosis in 26 of 69 (38%).  The most common 
CSF abnormality was high protein (> 50 mg/dl) seen in 55 of 71 
(77%) followed by pleocytosis (WBC > 5 cells/ml) in 48 of 72 (66%). 
The Infectious Diseases Society of America (IDSA) guidelines5 
recommend initial treatment of CNS histoplasmosis with liposomal 
amphotericin B for four to six weeks followed by itraconazole for 
at least one year. The best triazole after induction therapy remains 
unclear. Previous animal model studies for histoplasma meningitis 
showed that fluconazole was inferior to itraconazole despite achiev-
ing a better concentration in the CSF.6,7
This case highlighted that CNS histoplasmosis can present as 
meningoencephalitis and stroke in immunocompetent patients. Cli-
nicians should keep a high index of suspicion for CNS histoplasmosis 
in patients presenting with subacute/chronic meningoencephalitis, 
stroke, or brain lesion in histoplasma endemic regions. 
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